Sponsor

pharmaand GmbH

Austria Taborstrasse 1, 1020 Vienna, Austria

About the sponsor

pharmaand GmbH supports clinical research in ovarian epithelial cancer, including advanced disease and high-grade epithelial ovarian cancer. Its activity also extends to fallopian tube cancer and related primary peritoneal cancer populations.

Maintenance treatment in ovarian cancer
Platinum-sensitive disease
Advanced gynecologic malignancies

The sponsor’s research interest is centered on post-treatment disease control in women with platinum-responsive gynecologic cancers.

About Specializations

pharmaand GmbH runs clinical trials in conditions such as Malignant peritoneal neoplasm, Fallopian tube cancer, Ovarian epithelial cancer, among others.

All trials